Hypoxia Predicts Aggressive Growth and Spontaneous Metastasis Formation from Orthotopically Grown Primary Xenografts of Human Pancreatic Cancer
Authors:
- 13 April 2011
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 71 (8) , 3110-3120
Abstract
Hypoxia in solid tumors is associated with treatment resistance and increased metastatic potential. Although hypoxia has been reported in pancreatic cancer patients, there is little direct evidence that this contributes to their overall poor prognosis. To address this, we examined the associations between hypoxia and biological aggression in a series of patient-derived xenografts grown orthotopically. Early passage xenografts were established from 16 patients undergoing surgery for pancreatic cancer and maintained in the pancreas of immune-deprived mice. Hypoxic cells were labeled using the 2-nitroimidazole probe EF5 and stained for immunofluorescence microscopy of tissue sections or as cell suspensions for flow cytometry. Bromodeoxyuridine (BrdUrd) uptake, microvessel density, cleaved caspase-3, and the differentiation markers E-cadherin, cytokeratin 19, and vimentin were analyzed in relation to hypoxia. Orthotopic implants closely resembled the histology of the original surgical samples. The 16 primary xenografts showed a wide range in their growth rates and metastatic potential, reminiscent of the spectrum of behavior seen in the clinic. EF5 labeling, tumor growth rates, and metastatic patterns were highly consistent within replicates, indicating a significant transmissible (genetic or epigenetic) component. Hypoxia was highly correlated with rapid tumor growth, increased BrdUrd uptake, and with spontaneous metastasis formation. mRNA expression analysis showed increased expression of genes involved in cell survival and proliferation in the hypoxic models. The results suggest that hypoxia is a major adverse prognostic factor in pancreatic cancer patients and support the introduction of techniques to measure hypoxia directly in patients and the development of treatment protocols to target hypoxia. Cancer Res; 71(8); 3110–20. ©2011 AACR.Keywords
All Related Versions
This publication has 44 references indexed in Scilit:
- Distant metastasis occurs late during the genetic evolution of pancreatic cancerNature, 2010
- Antitumour activity of a potent MEK inhibitor RDEA119/BAY 869766 combined with rapamycin in human orthotopic primary pancreatic cancer xenograftsBMC Cancer, 2010
- Tumour necrosis is a postoperative prognostic marker for pancreatic cancer patients with a high interobserver reproducibility in histological evaluationBritish Journal of Cancer, 2010
- International network of cancer genome projectsNature, 2010
- Prognostic Significance of Tumorigenic Cells With Mesenchymal Features in Pancreatic AdenocarcinomaJNCI: Journal of the National Cancer Institute, 2010
- NAViGaTOR: Network Analysis, Visualization and Graphing TorontoBioinformatics, 2009
- Activity of a novel, dual PI3-kinase/mTor inhibitor NVP-BEZ235 against primary human pancreatic cancers grown as orthotopic xenograftsBritish Journal of Cancer, 2009
- Notch signaling mediates hypoxia-induced tumor cell migration and invasionProceedings of the National Academy of Sciences, 2008
- uPAR induces epithelial–mesenchymal transition in hypoxic breast cancer cellsJournal of Cell Biology, 2007
- Hypoxia — a key regulatory factor in tumour growthNature Reviews Cancer, 2002